Denali Therapeutics Inc. (DNLI) PT Raised to $38 at BTIG
BTIG analyst Thomas Shrader raised the price target on Denali Therapeutics Inc ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
